Suggest Your Website
Guaranteed review within the next 15 business days. (One Time Fee - $39.99)
Guaranteed review within the next 15 business days. (One Time Fee - $39.99)
Arimidex
Information from AstraZeneca about ARIMIDEX. approved for postmenopausal women with hormone receptor-positive early breast cancer.
Information from AstraZeneca about ARIMIDEX. approved for postmenopausal women with hormone receptor-positive early breast cancer.
Caprelsa (vandetanib)
For the treatment of symptomatic or progressive medullary thyroid cancer. Full prescribing information and warnings.
For the treatment of symptomatic or progressive medullary thyroid cancer. Full prescribing information and warnings.
ERBITUX (Cetuximab)
Learn about a treatment option for metastatic colorectal cancer and an initial treatment option for locally or regionally advanced head and neck cancer.
Learn about a treatment option for metastatic colorectal cancer and an initial treatment option for locally or regionally advanced head and neck cancer.
FASLODEX: Treatment for Metastatic Breast Cancer
For treatment of metastatic breast cancer in postmenopausal women with hormone receptor-positive metastatic breast cancer that has progressed following therapy with a hormonal treatment like Tamoxifen.
For treatment of metastatic breast cancer in postmenopausal women with hormone receptor-positive metastatic breast cancer that has progressed following therapy with a hormonal treatment like Tamoxifen.
Hycamtin
Information about the use of this drug for treatment of small cell lung cancer and ovarian cancer. Includes a glossary, information for care givers, and tips for patients.
Information about the use of this drug for treatment of small cell lung cancer and ovarian cancer. Includes a glossary, information for care givers, and tips for patients.
Proleukin (Aldesleukin)
Indicated for the treatment of adults with metastatic renal cell carcinoma and metastatic melanoma. Information about kidney cancer and treatment.
Indicated for the treatment of adults with metastatic renal cell carcinoma and metastatic melanoma. Information about kidney cancer and treatment.
Revlimid
Information provided by Celgene Corporation about this treatment for del 5q MDS (myelodysplastic syndrome).
Information provided by Celgene Corporation about this treatment for del 5q MDS (myelodysplastic syndrome).
Sancuso : Patch for CINV
Patch for chemotherapy induced nausea and vomiting providing 5 days of coverage for cancer patients.
Patch for chemotherapy induced nausea and vomiting providing 5 days of coverage for cancer patients.
SPRYCEL (dasatinib)
Offers information for consumers in the U.S. from Bristol-Myers Squibb. Treatment option for adult patients with CML.
Offers information for consumers in the U.S. from Bristol-Myers Squibb. Treatment option for adult patients with CML.
Valchlor (mechlorethamine) gel
An alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (MF‑CTCL) in patients who have received prior skin-directed therapy.
An alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (MF‑CTCL) in patients who have received prior skin-directed therapy.
Velcade.info
Gives information on Velcade (bortezomib), medication for multiple myeloma treatment. Including general characteristics and pharmacological properties.
Gives information on Velcade (bortezomib), medication for multiple myeloma treatment. Including general characteristics and pharmacological properties.
Xeloda Cancer Drug
Information about an oral chemotherapy that's proven to fight certain types of cancer and is the first FDA-approved treatment of advanced breast and colorectal cancers.
Information about an oral chemotherapy that's proven to fight certain types of cancer and is the first FDA-approved treatment of advanced breast and colorectal cancers.
Suggest Your Website || About Us
Copyright © 2001-2024 JoeAnt.com. All rights reserved.
Use of this site is subject to our Terms of Service.